CAM
SGMO

Cresset Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Cresset Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21,855
Closed -$197K – 1279
2021
Q3 		$197K Buy
21,855
+44
+0.2% +$435 ﹤0.01% 1037
2021
Q2 		$261K Buy
21,811
+9,530
+78% +$108K ﹤0.01% 839
2021
Q1 		$153K Buy
+12,281
New +$165K ﹤0.01% 886

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cresset Asset Management's SGMO Position: Q4 2021 in Review

Cresset Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 21,855 shares — an estimated $197K sold.

Cresset Asset Management first reported a position in SGMO in Q1 2021 and held it in 3 quarters. The position peaked at $261K in Q2 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

  • Cresset Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • Cresset Asset Management sold 21,855 SANGAMO THERAPEUTICS INC shares in Q4 2021, an estimated $197K.
  • Cresset Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2021 and held it in 3 quarters.
  • Cresset Asset Management's SANGAMO THERAPEUTICS INC position peaked at $261K in Q2 2021.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on Cresset Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.